戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -bearing mice immunocompromised by sublethal whole-body radiation.
2 ing toxicity for many chemotherapy drugs and whole-body radiation.
3 performed to determine the maximum tolerated whole-body radiation-absorbed dose of fractionated (131)
4  after Chernobyl was very different from the whole body radiation after the atomic bombs.
5                     This study evaluated the whole-body radiation burden of anti-(18)F-FACBC in human
6 y agents, particularly alkylating agents and whole body radiation, can be increased three- to fivefol
7 ti-B1 antibody needed to deliver a specified whole-body radiation dose (generally 75 cGy) to patients
8 ed cells or platelets correlated with higher whole-body radiation dose (P <or=.04).
9 I-MIBG activity per kilogram correlated with whole-body radiation dose and hematologic toxicity.
10                                The effective whole-body radiation dose for (124)I-omburtamab was 0.49
11                                   The median whole-body radiation dose was 2.92 Gy.
12                                   The median whole-body radiation dose was 228 cGy (range, 57-650 cGy
13                              The average NPA whole-body radiation dose was 3.17 x 10(-3) mSv per MBq
14                The ratio of average tumor to whole-body radiation dose was 49:1.
15                                          The whole-body radiation dose was derived from daily 1-m exp
16  useful predictor of hematotoxicity, whereas whole-body radiation dose was the most useful predictor
17 ) RM- and organ-absorbed doses and effective whole-body radiation dose were obtained using dose conve
18 mor, more extensive bone involvement, higher whole-body radiation dose, and longer time from diagnosi
19 y was established as the maximally tolerated whole-body radiation dose.
20                                              Whole-body radiation doses were escalated from 25 to 85
21                                              Whole-body radiation dosimetry of 11C-raclopride was per
22                                The estimated whole-body radiation effective dose was approximately 0.
23 yrogen stimulation has significantly reduced whole body radiation exposure as compared with the hypot
24 ubjects underwent whole-body PET to estimate whole-body radiation exposure (effective dose).
25 nd critical for the outcome after accidental whole-body radiation exposure.
26                                    Organ and whole-body radiation exposures were calculated using OLI
27 ne marrow ablation and are more resistant to whole-body radiation-induced lethality.
28 ent on evidence from exposure to atomic bomb whole body radiation, leading to increases in a wide ran
29 hts from various cohorts exposed to uniform, whole-body radiation or to partial-body irradiation, and
30  would deliver a specified centigray dose of whole-body radiation predicted by the tracer dose.
31                                         Mean whole-body radiation was 0.23 mGy/MBq, and mean organ do